The current data on increased use of methamphetamine and cocaine by patients on medication for opioid use disorder (MOUD) will be reviewed. After describing clinical concerns, including decreased retention on MOUD, psychosis, and stimulant dependence, current evidence-based treatments will be covered. Participants in this webinar will be able to:
Explain the current epidemiology of cocaine and methamphetamine by individuals treated with MOUD in the US
Describe the most common clinical challenges experienced by people on MOUD with stimulant use disorder
Review and discuss the current evidence-based practices for the treatment of individuals on MOUD with stimulant use disorder
Monday, April 27, 2020
About the Presenter
Richard Rawson, Ph.D Richard Rawson is an Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. He has conducted an extensive portfolio of research on cocaine and methamphetamine, including projects on behavioral and medication treatments, with brain imaging measures. He was a member of the Federal Methamphetamine Advisory Group for Attorney General Janet Reno. During the past decade, he has worked with NIDA, SAMHSA, the US State Department, the World Heath Organization and the United Nations Office of Drugs and Crime on international substance abuse research and training projects, exporting US technology and addiction science throughout the world. Dr. Rawson has published 3 books, 40 book chapters and over 240 professional papers and annually conducts numerous workshops, paper presentations and training sessions.